Breast cancer and reduction mammoplasty: The role of routine pre-operative mammography

European Journal of Surgical Oncology

Volumn 23, Issue 4, 1997, Pages 341-342

  Van Der Torre, P M ^a   Butzelaar, R M J M ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Breast neoplasms; Mammography; Mammoplasty

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST REDUCTION; CASE REPORT; FEMALE; HUMAN; MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 0030766960     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(97)90885-4     Document Type: Article

References (17)

1. SIG Zorginformaiie 1995. Utrecht: SIG Coöperatie U.A., 1995.
2. Cathcart RS, Hagerty RC. Preoperative and postoperative considerations in elective breast operations. Ann Plast Surg 1989; 22: 533-8.
3. Dinner MI, Sheldon, Artz J. Carcinoma of the breast occurring in routine reduction mammoplasty. Plast Reconstr Surg 1989; 83: 1042-4.
4. Perras C, Papillon J. The value of mammography in cosmetic surgery of the breasts. Plast Reconstr Surg 1973; 52: 132-7.
5. Snyderman RK, Lizardo JG. Statistical study of malignancies found before, during, or after routine breast plastic operations. Plast Reconstr Surg 1960; 25: 253-6.
6. Bondeson L, Linell F, Ringberg A. Breast reductions: what to do with all the tissue specimens? Histopathology 1985; 9: 281-5.
7. Karabela-Bouropoulou V, Liapi-Avgeri G, Iliopoulou E, et al. Histological findings in breast tissue specimens from reduction mammoplasties. Path Res Pract 1994; 190: 792-8.
8. Fletcher SW, Black W, Harris R, et al. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 1993; 85: 1644-56.
9. Kopans DB. Screening mammography in women 40 to 49 years of age: yes. Imp Adv Oncol 1995; 231-41.
10. Baines CJ. Screening mammography in women 40 to 49 years of age: no. Imp Adv Oncol 1995; 243-51.
11. Tubiana M, Holland R, Kopans DB, et al. Commision of the European Communities "Europe against cancer" programme. European School of Oncology Advisory report: Management of non-palpable and small lesions found in mass breast screening. Ear J Cancer 1994; 30A: 538-47.
12. de Koning HJ, van Ingeveld BM, van Ootmarssen GJ, et al. De Kosten en Effecten van Bevolkingsonderzoek op Borstkanker. Rotterdam: Erasmus Universiteit, Instituut Maatschappelijke Gezondheidszorg, 1990.
13. Schwartz GF, Feig SA. Management of clinically occult (nonpalpable) breast lesions. Obs Gyn Clin N Am 1994; 21: 621-37.
14. Allen MJ, Thompson WD, Stuart RC, et al. Management of non-palpable breast lesions detected mammographically. Br J Surg 1994; 8: 543-5.
15. Franceschi D, Crowe JP, Lie S, et al. Not all nonpalpable breast cancers are alike. Arch Surg 1991; 126: 967-71.
16. Haffty BG, Kornguth P, Fischer D, et al. Mammographically detected breast cancer, results with conservative surgery and radiation therapy. Cancer 1991; 67: 2801-4.
17. Schwartz GF, Carter DL, Conant EF, et al. Mammographically detected breast cancer: nonpalpable is not a synonym for inconsequential. Cancer 1994; 73: 1660-5.